{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:35:07Z","timestamp":1771479307761,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"T32","award":["AG078110"],"award-info":[{"award-number":["AG078110"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG068215"],"award-info":[{"award-number":["AG068215"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biogerontology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10522-025-10359-z","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T18:43:05Z","timestamp":1764355385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circadian rhythm of amyloid-\u03b2 in the olfactory bulb and cerebellum of wild-type and APPxPS1 knock-in mice indicates a loss of rhythmicity in regions more vulnerable to amyloid pathology"],"prefix":"10.1007","volume":"27","author":[{"given":"Valeria A.","family":"Buzinova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savannah M.","family":"Turton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Padgett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Tyler","family":"Maisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleigh R.","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam D.","family":"Bachstetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Sunderam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce F.","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn J.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Paul","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"10359_CR1","unstructured":"2025 Alzheimer\u2019s disease facts and figures (2025) A. D. 2025. https:\/\/www.alz.org\/getmedia\/ef8f48f9-ad36-48ea-87f9-b74034635c1e\/alzheimers-facts-and-figures.pdf"},{"issue":"6","key":"10359_CR2","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1093\/brain\/awab434","volume":"145","author":"EE Abrahamson","year":"2022","unstructured":"Abrahamson EE, Kofler JK, Becker CR, Price JC, Newell KL, Ghetti B, Murrell JR, McLean CA, Lopez OL, Mathis CA, Klunk WE, Villemagne VL, Ikonomovic MD (2022) 11C-PiB PET can underestimate brain amyloid-beta burden when cotton wool plaques are numerous. Brain 145(6):2161\u20132176. https:\/\/doi.org\/10.1093\/brain\/awab434","journal-title":"Brain"},{"issue":"4","key":"10359_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS (2014) Amyloid-\u03b2 and tau. JAMA Neurol 71(4):505. https:\/\/doi.org\/10.1001\/jamaneurol.2013.5847","journal-title":"JAMA Neurol"},{"issue":"3","key":"10359_CR4","first-page":"195","volume":"1","author":"AA Borbely","year":"1982","unstructured":"Borbely AA (1982) A two process model of sleep regulation. Hum Neurobiol 1(3):195\u2013204","journal-title":"Hum Neurobiol"},{"key":"10359_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-802395-2.00023-7","volume":"145","author":"AL Calderon-Garciduenas","year":"2017","unstructured":"Calderon-Garciduenas AL, Duyckaerts C (2017) Alzheimer disease. Handb Clin Neurol 145:325\u2013337. https:\/\/doi.org\/10.1016\/B978-0-12-802395-2.00023-7","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10359_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jalz.2014.07.001","volume":"11","author":"V Chouraki","year":"2015","unstructured":"Chouraki V, Beiser A, Younkin L, Preis SR, Weinstein G, Hansson O, Skoog I, Lambert JC, Au R, Launer L, Wolf PA, Younkin S, Seshadri S (2015) Plasma amyloid-beta and risk of Alzheimer\u2019s disease in the Framingham Heart Study. Alzheimers Dement 11(3):249-257 e241. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.001","journal-title":"Alzheimers Dement"},{"issue":"24","key":"10359_CR7","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1523\/JNEUROSCI.23-24-08532.2003","volume":"23","author":"P Das","year":"2003","unstructured":"Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE (2003) Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-\/- knock-out mice. J Neurosci 23(24):8532\u20138538. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-24-08532.2003","journal-title":"J Neurosci"},{"issue":"5","key":"10359_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/s0197-4580(01)00245-7","volume":"22","author":"P Das","year":"2001","unstructured":"Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE (2001) Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol Aging 22(5):721\u2013727. https:\/\/doi.org\/10.1016\/s0197-4580(01)00245-7","journal-title":"Neurobiol Aging"},{"key":"10359_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1742-2094-3-17","volume":"3","author":"P Das","year":"2006","unstructured":"Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE (2006) Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy. J Neuroinflammation 3:17. https:\/\/doi.org\/10.1186\/1742-2094-3-17","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10359_CR10","doi-asserted-by":"publisher","first-page":"e89998","DOI":"10.1371\/journal.pone.0089998","volume":"9","author":"JA Dobrowolska","year":"2014","unstructured":"Dobrowolska JA, Kasten T, Huang Y, Benzinger TL, Sigurdson W, Ovod V, Morris JC, Bateman RJ (2014) Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system. PLoS ONE 9(3):e89998. https:\/\/doi.org\/10.1371\/journal.pone.0089998","journal-title":"PLoS ONE"},{"issue":"2","key":"10359_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.expneurol.2012.05.011","volume":"236","author":"MJ Duncan","year":"2012","unstructured":"Duncan MJ, Smith JT, Franklin KM, Beckett TL, Murphy MP, St Clair DK, Donohue KD, Striz M, O\u2019Hara BF (2012) Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer\u2019s disease. Exp Neurol 236(2):249\u2013258. https:\/\/doi.org\/10.1016\/j.expneurol.2012.05.011","journal-title":"Exp Neurol"},{"issue":"50","key":"10359_CR12","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1523\/JNEUROSCI.1318-23.2023","volume":"43","author":"EA Eckman","year":"2023","unstructured":"Eckman EA, Clausen DM, Sole-Domenech S, Lee CW, Sinobas-Pereira C, Domalewski RJ, Nichols MR, Pacheco-Quinto J (2023) Nascent Abeta42 fibrillization in synaptic endosomes precedes plaque formation in a mouse model of Alzheimer\u2019s-like beta-amyloidosis. J Neurosci 43(50):8812\u20138824. https:\/\/doi.org\/10.1523\/JNEUROSCI.1318-23.2023","journal-title":"J Neurosci"},{"key":"10359_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.dadm.2017.07.004","volume":"8","author":"N Fandos","year":"2017","unstructured":"Fandos N, Perez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, Doecke J, Fowler C, Masters CL, Sarasa M, Group AR (2017) Plasma amyloid beta 42\/40 ratios as biomarkers for amyloid beta cerebral deposition in cognitively normal individuals. Alzheimers Dement (Amst) 8:179\u2013187. https:\/\/doi.org\/10.1016\/j.dadm.2017.07.004","journal-title":"Alzheimers Dement (Amst)"},{"key":"10359_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032117","author":"I Fatuzzo","year":"2023","unstructured":"Fatuzzo I, Niccolini GF, Zoccali F, Cavalcanti L, Bellizzi MG, Riccardi G, de Vincentiis M, Fiore M, Petrella C, Minni A, Barbato C (2023) Neurons, nose, and neurodegenerative diseases: olfactory function and cognitive impairment. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032117","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10359_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0197-4580(01)00330-x","volume":"23","author":"DG Flood","year":"2002","unstructured":"Flood DG, Reaume AG, Dorfman KS, Lin YG, Lang DM, Trusko SP, Savage MJ, Annaert WG, De Strooper B, Siman R, Scott RW (2002) FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction. Neurobiol Aging 23(3):335\u2013348. https:\/\/doi.org\/10.1016\/s0197-4580(01)00330-x","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10359_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0006-291x(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120(3):885\u2013890. https:\/\/doi.org\/10.1016\/s0006-291x(84)80190-4","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10359_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/archneur.64.3.354","volume":"64","author":"NR Graff-Radford","year":"2007","unstructured":"Graff-Radford NR, Crook JE, Lucas J, Boeve BF, Knopman DS, Ivnik RJ, Smith GE, Younkin LH, Petersen RC, Younkin SG (2007) Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol 64(3):354\u2013362. https:\/\/doi.org\/10.1001\/archneur.64.3.354","journal-title":"Arch Neurol"},{"issue":"10","key":"10359_CR18","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The amyloid-beta pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10359_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ajpath.2011.09.034","volume":"180","author":"CJ Holler","year":"2012","unstructured":"Holler CJ, Webb RL, Laux AL, Beckett TL, Niedowicz DM, Ahmed RR, Liu Y, Simmons CR, Dowling AL, Spinelli A, Khurgel M, Estus S, Head E, Hersh LB, Murphy MP (2012) BACE2 expression increases in human neurodegenerative disease. Am J Pathol 180(1):337\u2013350. https:\/\/doi.org\/10.1016\/j.ajpath.2011.09.034","journal-title":"Am J Pathol"},{"key":"10359_CR20","doi-asserted-by":"publisher","first-page":"942704","DOI":"10.3389\/fphys.2022.942704","volume":"13","author":"HC Hollis","year":"2022","unstructured":"Hollis HC, Francis JN, Anafi RC (2022) Multi-tissue transcriptional changes and core circadian clock disruption following intensive care. Front Physiol 13:942704. https:\/\/doi.org\/10.3389\/fphys.2022.942704","journal-title":"Front Physiol"},{"key":"10359_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2025.07.010","author":"HC Hollis","year":"2025","unstructured":"Hollis HC, Sharma A, Sheehan PW, Maggi LB Jr., Weber JD, Hammarlund JA, Bennett DA, Menon V, Musiek ES, Anafi RC (2025) Reconstructed cell-type-specific rhythms in human brain link Alzheimer\u2019s pathology, circadian stress, and ribosomal disruption. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2025.07.010","journal-title":"Neuron"},{"issue":"147","key":"10359_CR22","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 4(147):147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748","journal-title":"Sci Transl Med"},{"issue":"46","key":"10359_CR23","doi-asserted-by":"publisher","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","volume":"33","author":"JJ Iliff","year":"2013","unstructured":"Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A, Plog BA, Liao Y, Deane R, Nedergaard M (2013) Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci 33(46):18190\u201318199. https:\/\/doi.org\/10.1523\/JNEUROSCI.1592-13.2013","journal-title":"J Neurosci"},{"issue":"1","key":"10359_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JAD-230527","volume":"97","author":"CE Johnson","year":"2024","unstructured":"Johnson CE, Duncan MJ, Murphy MP (2024) Sex and sleep disruption as contributing factors in Alzheimer\u2019s disease. J Alzheimers Dis 97(1):31\u201374. https:\/\/doi.org\/10.3233\/JAD-230527","journal-title":"J Alzheimers Dis"},{"issue":"5955","key":"10359_CR25","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"J-E Kang","year":"2009","unstructured":"Kang J-E, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM (2009) Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle. Science 326(5955):1005\u20131007. https:\/\/doi.org\/10.1126\/science.1180962","journal-title":"Science"},{"issue":"6106","key":"10359_CR26","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325(6106):733\u2013736. https:\/\/doi.org\/10.1038\/325733a0","journal-title":"Nature"},{"issue":"5","key":"10359_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm1235","volume":"11","author":"T Kukar","year":"2005","unstructured":"Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, Ozols VV, Anastasiadis PZ, Das P, Fauq A, Koo EH, Golde TE (2005) Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med 11(5):545\u2013550. https:\/\/doi.org\/10.1038\/nm1235","journal-title":"Nat Med"},{"issue":"1","key":"10359_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1172\/JCI25410","volume":"116","author":"Y Levites","year":"2006","unstructured":"Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE (2006a) Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest 116(1):193\u2013201. https:\/\/doi.org\/10.1172\/JCI25410","journal-title":"J Clin Invest"},{"issue":"46","key":"10359_CR29","doi-asserted-by":"publisher","first-page":"11923","DOI":"10.1523\/JNEUROSCI.2795-06.2006","volume":"26","author":"Y Levites","year":"2006","unstructured":"Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P, Golde TE (2006b) Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice. J Neurosci 26(46):11923\u201311928. https:\/\/doi.org\/10.1523\/JNEUROSCI.2795-06.2006","journal-title":"J Neurosci"},{"key":"10359_CR30","doi-asserted-by":"publisher","first-page":"36035","DOI":"10.1038\/srep36035","volume":"6","author":"Z Ma","year":"2016","unstructured":"Ma Z, Jiang W, Zhang EE (2016) Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer\u2019s disease-risk genes. Sci Rep 6:36035. https:\/\/doi.org\/10.1038\/srep36035","journal-title":"Sci Rep"},{"issue":"8","key":"10359_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11882-018-0796-4","volume":"18","author":"C Marin","year":"2018","unstructured":"Marin C, Vilas D, Langdon C, Alobid I, Lopez-Chacon M, Haehner A, Hummel T, Mullol J (2018) Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep 18(8):42. https:\/\/doi.org\/10.1007\/s11882-018-0796-4","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"10359_CR32","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, DeLucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47(2):191\u2013199. https:\/\/doi.org\/10.1016\/j.neuron.2005.06.030","journal-title":"Neuron"},{"key":"10359_CR33","doi-asserted-by":"publisher","unstructured":"Molcan L (2023) Time distributed data analysis by Cosinor.Online application. https:\/\/doi.org\/10.1101\/805960","DOI":"10.1101\/805960"},{"issue":"5","key":"10359_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC Muller","year":"2017","unstructured":"Muller UC, Deller T, Korte M (2017) Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci 18(5):281\u2013298. https:\/\/doi.org\/10.1038\/nrn.2017.29","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10359_CR101","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H 3rd (2010) Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis 19(1):311\u2013323. https:\/\/doi.org\/10.3233\/JAD-2010-1221","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10359_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.nbd.2007.06.002","volume":"27","author":"MP Murphy","year":"2007","unstructured":"Murphy MP, Beckett TL, Ding Q, Patel E, Markesbery WR, St Clair DK, LeVine H, Keller JN (2007) Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol Dis 27(3):301\u2013311. https:\/\/doi.org\/10.1016\/j.nbd.2007.06.002","journal-title":"Neurobiol Dis"},{"key":"10359_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166945","author":"MP Murphy","year":"2023","unstructured":"Murphy MP, Buzinova VA, Johnson CE (2023) The Amyloid-\u03b2 Peptide: Guilty as Charged? Biochem Biophys Acta Mol Basis Dis. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166945","journal-title":"Biochem Biophys Acta Mol Basis Dis"},{"key":"10359_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2023.01.009","volume":"516","author":"HC Murray","year":"2023","unstructured":"Murray HC, Saar G, Bai L, Bouraoud N, Dodd S, Highet B, Ryan B, Curtis MA, Koretsky A, Belluscio L (2023) Progressive spread of beta-amyloid pathology in an olfactory-driven amyloid precursor protein mouse model. Neuroscience 516:113\u2013124. https:\/\/doi.org\/10.1016\/j.neuroscience.2023.01.009","journal-title":"Neuroscience"},{"issue":"4","key":"10359_CR52","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/ana.23633","volume":"72","author":"DM Niedowicz","year":"2012","unstructured":"Niedowicz DM, Beckett TL, Matveev S, Weidner AM, Baig I, Kryscio RJ, Mendiondo MS, LeVine H 3rd, Keller JN, Murphy MP (2012) Pittsburgh compound B and the postmortem diagnosis of Alzheimer disease. Ann Neurol 72(4):564\u2013570. https:\/\/doi.org\/10.1002\/ana.23633","journal-title":"Ann Neurol"},{"issue":"38","key":"10359_CR38","doi-asserted-by":"publisher","first-page":"23380","DOI":"10.1074\/jbc.271.38.23380","volume":"271","author":"AG Reaume","year":"1996","unstructured":"Reaume AG, Howland DS, Trusko SP, Savage MJ, Lang DM, Greenberg BD, Siman R, Scott RW (1996) Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer\u2019s disease mutations and a \u201chumanized\u201d Abeta sequence. J Biol Chem 271(38):23380\u201323388. https:\/\/doi.org\/10.1074\/jbc.271.38.23380","journal-title":"J Biol Chem"},{"issue":"150","key":"10359_CR39","doi-asserted-by":"publisher","first-page":"150ra122","DOI":"10.1126\/scitranslmed.3004291","volume":"4","author":"JH Roh","year":"2012","unstructured":"Roh JH, Huang Y, Bero AW, Kasten T, Stewart FR, Bateman RJ, Holtzman DM (2012) Disruption of the sleep-wake cycle and diurnal fluctuation of beta-amyloid in mice with Alzheimer\u2019s disease pathology. Sci Transl Med 4(150):150ra122. https:\/\/doi.org\/10.1126\/scitranslmed.3004291","journal-title":"Sci Transl Med"},{"key":"10359_CR40","doi-asserted-by":"publisher","first-page":"721579","DOI":"10.3389\/fragi.2021.721579","volume":"2","author":"K Sato","year":"2021","unstructured":"Sato K, Takayama KI, Hashimoto M, Inoue S (2021) Transcriptional and post-transcriptional regulations of amyloid-beta precursor protein (APP) mRNA. Front Aging 2:721579. https:\/\/doi.org\/10.3389\/fragi.2021.721579","journal-title":"Front Aging"},{"key":"10359_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neuroscience.2015.01.035","volume":"290","author":"M Sethi","year":"2015","unstructured":"Sethi M, Joshi SS, Webb RL, Beckett TL, Donohue KD, Murphy MP, O\u2019Hara BF, Duncan MJ (2015) Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer\u2019s disease. Neuroscience 290:80\u201389. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.01.035","journal-title":"Neuroscience"},{"issue":"2","key":"10359_CR42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2174\/1570159X18666200429013041","volume":"19","author":"A Sharma","year":"2021","unstructured":"Sharma A, Sethi G, Tambuwala MM, Aljabali AAA, Chellappan DK, Dua K, Goyal R (2021) Circadian rhythm disruption and Alzheimer\u2019s disease: the dynamics of a vicious cycle. Curr Neuropharmacol 19(2):248\u2013264. https:\/\/doi.org\/10.2174\/1570159X18666200429013041","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10359_CR43","doi-asserted-by":"publisher","first-page":"e14264","DOI":"10.1002\/alz.14264","volume":"21","author":"LM Shaw","year":"2025","unstructured":"Shaw LM, Korecka M, Lee EB, Cousins KAQ, Vanderstichele H, Schindler SE, Tosun D, DeMarco ML, Brylska M, Wan Y, Burnham S, Sciulli A, Vulaj A, Tropea TF, Chen-Plotkin A, Wolk DA, Alzheimer\u2019s Disease Neuroimaging, I. (2025) ADNI biomarker core: a review of progress since 2004 and future challenges. Alzheimers Dement 21(1):e14264. https:\/\/doi.org\/10.1002\/alz.14264","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10359_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13195-020-00730-2","volume":"13","author":"G Son","year":"2021","unstructured":"Son G, Yoo SJ, Kang S, Rasheed A, Jung DH, Park H, Cho B, Steinbusch HWM, Chang KA, Suh YH, Moon C (2021) Region-specific amyloid-\u03b2 accumulation in the olfactory system influences olfactory sensory neuronal dysfunction in 5xFAD mice. Alzheimers Res Ther 13(1):4. https:\/\/doi.org\/10.1186\/s13195-020-00730-2","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10359_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S-I, Lipton SA, Xu H (2014) Oligomeric A\u03b2-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener 9(1):48. https:\/\/doi.org\/10.1186\/1750-1326-9-48","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10359_CR46","doi-asserted-by":"publisher","first-page":"167840","DOI":"10.1016\/j.bbadis.2025.167840","volume":"1871","author":"SM Turton","year":"2025","unstructured":"Turton SM, Padgett S, Maisel MT, Johnson CE, Buzinova VA, Barth SE, Kohler K, Spearman HM, Macheda T, Manauis EC, Guo LZ, Whitlock HR, Bachstetter AD, Sunderam S, O\u2019Hara BF, Duncan MJ, Murphy MP (2025) Interactions between daily sleep-wake rhythms, gamma-secretase, and amyloid-beta peptide pathology point to complex underlying relationships. Biochim Biophys Acta Mol Basis Dis 1871(6):167840. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167840","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10359_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant R, Goldstein LSB, Ossenkoppele R (2020) Amyloid-beta-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci 21(1):21\u201335. https:\/\/doi.org\/10.1038\/s41583-019-0240-3","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10359_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41386-019-0478-5","volume":"45","author":"C Wang","year":"2020","unstructured":"Wang C, Holtzman DM (2020) Bidirectional relationship between sleep and Alzheimer\u2019s disease: role of amyloid, tau, and other factors. Neuropsychopharmacology 45(1):104\u2013120. https:\/\/doi.org\/10.1038\/s41386-019-0478-5","journal-title":"Neuropsychopharmacology"},{"key":"10359_CR49","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3389\/fgene.2014.00088","volume":"5","author":"SJ Webster","year":"2014","unstructured":"Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ (2014) Using mice to model Alzheimer\u2019s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 5:88. https:\/\/doi.org\/10.3389\/fgene.2014.00088","journal-title":"Front Genet"},{"issue":"3","key":"10359_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/alzrt182","volume":"5","author":"SJ Webster","year":"2013","unstructured":"Webster SJ, Bachstetter AD, Van Eldik LJ (2013) Comprehensive behavioral characterization of an APP\/PS-1 double knock-in mouse model of Alzheimer\u2019s disease. Alzheimers Res Ther 5(3):28. https:\/\/doi.org\/10.1186\/alzrt182","journal-title":"Alzheimers Res Ther"},{"issue":"6156","key":"10359_CR51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O\u2019Donnell J, Christensen DJ, Nicholson C, Iliff JJ, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342(6156):373\u2013377. https:\/\/doi.org\/10.1126\/science.1241224","journal-title":"Science"}],"container-title":["Biogerontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10522-025-10359-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10522-025-10359-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10522-025-10359-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:39:32Z","timestamp":1771396772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10522-025-10359-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10359"],"URL":"https:\/\/doi.org\/10.1007\/s10522-025-10359-z","relation":{},"ISSN":["1389-5729","1573-6768"],"issn-type":[{"value":"1389-5729","type":"print"},{"value":"1573-6768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to update in the figure 2 and 3.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BFO is the founder and CSO of Signal Solutions, LLC, which manufactured the PiezoSleep system used in this study. No other authors have competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}